SONNET BioTherapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
18.90
|
|
Average Rating
|
5.00
|
|
# Strong Buys
|
2
|
|
# Buys
|
0
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-1.51
|
-1.67
|
-0.16
|
-10.60%
|
|
2022-06-30
|
-1.96
|
-1.82
|
0.14
|
7.14%
|
|
2022-03-31
|
-1.68
|
-1.96
|
-0.28
|
-16.67%
|
|
2021-12-31
|
-2.66
|
-1.40
|
1.26
|
47.37%
|
|
2021-09-30
|
-3.08
|
-2.45
|
0.63
|
20.45%
|
|
2021-06-30
|
-6.76
|
-0.32
|
6.44
|
95.27%
|
|
2021-03-31
|
0.00
|
-0.32
|
0.00
|
0.00%
|
|
2020-12-31
|
-5.72
|
-0.34
|
5.38
|
94.06%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-5.45
|
|
2021-12-31
|
-4.49
|
|
2020-12-31
|
-5.48
|
|
2019-12-31
|
-44.38
|
|
2018-12-31
|
-36.55
|
|
2017-12-31
|
-1.78
|
|
2016-12-31
|
-4.30
|
|
2015-12-31
|
-4.00
|
|
2014-12-31
|
-1717.14
|
|
2013-12-31
|
-4385.09
|
|
2012-12-31
|
-5686.34
|
|
2009-12-31
|
-1752.66
|
|
2008-12-31
|
-5272.02
|